4BIO Capital is a London-based venture capital firm specializing in life sciences investments. The firm focuses on advanced therapies that address significant unmet medical and social needs. Their investment strategy encompasses various therapeutic areas, including gene therapy, cell therapy, RNA-based therapy, targeted therapies, and microbiome-based treatments.